Back

Sodium–glucose cotransporter-2 inhibitors as adjunctive therapy in left ventricular assist device recipients without diabetes: a real-world cohort study

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Advanced heart failure: from pharmacology to mechanical support Ventricular Assist Devices ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Juliana Giorgi

Albert Einstein Israelite Hospital, Sao Paulo (Brazil)

6 More presentations in this session

Presentation thumbnail
Does management at specialized LVAD center improve survival in AMI-related cardiogenic shock treated with ECPELLA?
Doctor M. Nakamura (Toyama, JP)
Abstract Slides Video
Presentation thumbnail
Long-term trajectory and prognostic value of N-terminal pro-brain natriuretic peptide in patients with contemporary left ventricular assist device
Doctor Y. Luo (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Pre-implant right heart catheterization and liver biomarkers in left ventricular assist device candidates
Mr P. Jahangiri (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Transcatheter strategy for severe mitral regurgitation requiring percutaneous ventricular assist device support
Doctor T. Isawa (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
Right heart function paradoxically predicts systemic circulatory failure during ventricular tachyarrhythmias in LVAD-supported patients
Doctor T. Watanabe (Fukuoka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced heart failure: from pharmacology to mechanical support

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy of sodium-glucose cotransporter - 2 inhibitors in patients after implantation of the left ventricular assist device
20 May 2023
thumbnail
Congress Session
Hypertension with cardiometabolic comorbidities: which drugs to select and which to avoid
30 August 2025
thumbnail
Congress Presentation
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
31 August 2025
thumbnail
Congress Presentation
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources